Cargando…
Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia
PURPOSE: To evaluate the performance and safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) for improvement of uncorrected near, intermediate and distance visual acuity in phakic subjects with myopia and presbyopia. DESIGN: Prospective multicenter study. METHODS: Presbyopi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509320/ https://www.ncbi.nlm.nih.gov/pubmed/32982164 http://dx.doi.org/10.2147/OPTH.S271858 |
_version_ | 1783585570096676864 |
---|---|
author | Packer, Mark Alfonso, Jose F Aramberri, Jaime Elies, Daniel Fernandez, Joaquin Mertens, Erik |
author_facet | Packer, Mark Alfonso, Jose F Aramberri, Jaime Elies, Daniel Fernandez, Joaquin Mertens, Erik |
author_sort | Packer, Mark |
collection | PubMed |
description | PURPOSE: To evaluate the performance and safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) for improvement of uncorrected near, intermediate and distance visual acuity in phakic subjects with myopia and presbyopia. DESIGN: Prospective multicenter study. METHODS: Presbyopic subjects who required an EDOF ICL in the range of −0.50 D to −18.00 D, exhibited ≤ 0.75 D refractive astigmatism and required from +1.00 to +2.50 D reading add were implanted bilaterally. Assessments at 6 months included uncorrected near, intermediate and distance visual acuities, defocus curves, contrast sensitivity, responses to the National Eye Institute Refractive Error Quality of Life Questionnaire and a Task Assessment Questionnaire. RESULTS: A total of 34 subjects completed the study. Investigators targeted emmetropia in all eyes. Mean binocular uncorrected near, intermediate and distance visual acuities measured logMAR −0.01 ± 0.05 (20/20), −0.02 ± 0.08 (20/19) and 0.07 ± 0.10 (20/23), respectively. Mean monocular uncorrected near, intermediate and distance visual acuities measured logMAR 0.068 ± 0.09 (20/23), 0.062 ± 0.10 (20/23) and 0.16 ± 0.12 (20/29). There were no clinically or statistically significant differences in contrast sensitivity between baseline and 6 months under any testing conditions. Subjects reported significant improvements in measures of vision-related quality of life and ability to perform tasks at all distances without glasses or contact lenses. Overall, satisfaction with the EDOF ICL was high: postoperatively, 91.2% of subjects were satisfied with their vision. CONCLUSION: This multicenter, prospective clinical investigation demonstrated the ability of the EDOF ICL to correct myopia and presbyopia, resulting in improvement of uncorrected near, intermediate and distance visual acuity without compromising the quality of vision. The EDOF ICL allowed subjects to perform tasks of daily living without glasses or contact lenses. Subjects reported significant improvements in quality of life with high levels of spectacle independence and satisfaction. |
format | Online Article Text |
id | pubmed-7509320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-75093202020-09-24 Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia Packer, Mark Alfonso, Jose F Aramberri, Jaime Elies, Daniel Fernandez, Joaquin Mertens, Erik Clin Ophthalmol Clinical Trial Report PURPOSE: To evaluate the performance and safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) for improvement of uncorrected near, intermediate and distance visual acuity in phakic subjects with myopia and presbyopia. DESIGN: Prospective multicenter study. METHODS: Presbyopic subjects who required an EDOF ICL in the range of −0.50 D to −18.00 D, exhibited ≤ 0.75 D refractive astigmatism and required from +1.00 to +2.50 D reading add were implanted bilaterally. Assessments at 6 months included uncorrected near, intermediate and distance visual acuities, defocus curves, contrast sensitivity, responses to the National Eye Institute Refractive Error Quality of Life Questionnaire and a Task Assessment Questionnaire. RESULTS: A total of 34 subjects completed the study. Investigators targeted emmetropia in all eyes. Mean binocular uncorrected near, intermediate and distance visual acuities measured logMAR −0.01 ± 0.05 (20/20), −0.02 ± 0.08 (20/19) and 0.07 ± 0.10 (20/23), respectively. Mean monocular uncorrected near, intermediate and distance visual acuities measured logMAR 0.068 ± 0.09 (20/23), 0.062 ± 0.10 (20/23) and 0.16 ± 0.12 (20/29). There were no clinically or statistically significant differences in contrast sensitivity between baseline and 6 months under any testing conditions. Subjects reported significant improvements in measures of vision-related quality of life and ability to perform tasks at all distances without glasses or contact lenses. Overall, satisfaction with the EDOF ICL was high: postoperatively, 91.2% of subjects were satisfied with their vision. CONCLUSION: This multicenter, prospective clinical investigation demonstrated the ability of the EDOF ICL to correct myopia and presbyopia, resulting in improvement of uncorrected near, intermediate and distance visual acuity without compromising the quality of vision. The EDOF ICL allowed subjects to perform tasks of daily living without glasses or contact lenses. Subjects reported significant improvements in quality of life with high levels of spectacle independence and satisfaction. Dove 2020-09-18 /pmc/articles/PMC7509320/ /pubmed/32982164 http://dx.doi.org/10.2147/OPTH.S271858 Text en © 2020 Packer et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Clinical Trial Report Packer, Mark Alfonso, Jose F Aramberri, Jaime Elies, Daniel Fernandez, Joaquin Mertens, Erik Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia |
title | Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia |
title_full | Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia |
title_fullStr | Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia |
title_full_unstemmed | Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia |
title_short | Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia |
title_sort | performance and safety of the extended depth of focus implantable collamer(®) lens (edof icl) in phakic subjects with presbyopia |
topic | Clinical Trial Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509320/ https://www.ncbi.nlm.nih.gov/pubmed/32982164 http://dx.doi.org/10.2147/OPTH.S271858 |
work_keys_str_mv | AT packermark performanceandsafetyoftheextendeddepthoffocusimplantablecollamerlensedoficlinphakicsubjectswithpresbyopia AT alfonsojosef performanceandsafetyoftheextendeddepthoffocusimplantablecollamerlensedoficlinphakicsubjectswithpresbyopia AT aramberrijaime performanceandsafetyoftheextendeddepthoffocusimplantablecollamerlensedoficlinphakicsubjectswithpresbyopia AT eliesdaniel performanceandsafetyoftheextendeddepthoffocusimplantablecollamerlensedoficlinphakicsubjectswithpresbyopia AT fernandezjoaquin performanceandsafetyoftheextendeddepthoffocusimplantablecollamerlensedoficlinphakicsubjectswithpresbyopia AT mertenserik performanceandsafetyoftheextendeddepthoffocusimplantablecollamerlensedoficlinphakicsubjectswithpresbyopia |